首页> 外国专利> Treatment method to abort and or reduce the severity of upper respiratory viral illness as well as to prevent upper respiratory viral illness in humans

Treatment method to abort and or reduce the severity of upper respiratory viral illness as well as to prevent upper respiratory viral illness in humans

机译:处理方法中止和降低上呼吸道病毒疾病的严重程度,并防止人类上呼吸道病毒疾病

摘要

Upper respiratory viral illness including influenza is a common worldwide problem. The consequences of these infections in any given population have a huge spectrum including losing several workdays all the way to severe illness with prolonged hospitalizations and death. While there are a wide variety of symptomatic treatments available, they are neither shown to alter the disease course nor prevent the occurrence of secondary complications. There are no options available to get rid of these infections before the infection becomes a full blown illness. After various preventive methods like vaccines, hand hygiene, wearing masks and avoiding exposure, the next best step is to make use of treatment methods that do not necessitate a doctor visit or expensive diagnostic tests, to get rid of the illness quickly. The inventor here describes an invention of a treatment method to abort and/or reducing the severity either in its duration or symptoms or both of upper respiratory viral illness using a unique gargling solution comprising of Menthol, Borneol and Sodium Chloride dissolved in warm water, wherein the three compounds work in synergy for the above mentioned purpose.;As I continued researching other additional ways to further improve outcomes in humans with upper respiratory viral illness, I also formulated an additional treatment method to create a multi target therapy. This additional oral treatment to be used in conjunction with the above gargling method to ensure the best outcome for everyone with the said illness but particularly for individuals whose immune system may be already stressed. This oral formulation is a carefully formulated mixture of Curcumina Longa root powder along with Curcumin extract, Piper Nigrum, Ascorbic acid, Zinc, Echinacea, Sambucus Nigra, Allium Sativum, Syzygium Aromaticum, Coleus Amboinicus and Zingiber Officinale to be taken orally.
机译:包括流感的上呼吸道病毒疾病是一个共同的全世界问题。这些感染在任何给定的人口中的后果都有一个巨大的频谱,包括延长住院和死亡的严重疾病的几个工作日。虽然有各种各样的有症状治疗方法,但它们既不显示出改变疾病过程,也没有防止发生继发性的发生。在感染成为全面爆发之前,没有可用于摆脱这些感染的选择。经过各种预防性方法,如疫苗,手工卫生,戴口罩和避免曝光,下一个最佳步骤是利用治疗方法,不需要医生访问或昂贵的诊断测试,快速摆脱疾病。发明人这里描述了使用溶解在温水中的独特的漱口溶液中的治疗方法的发明方法中中止和/或降低上呼吸道病毒疾病的严重程度,其中对于上述目的,三种化合物在协同作用中工作。;因为我继续研究其他额外的方法,以进一步改善具有上呼吸道病毒疾病的人类的结果,我还配制了一种额外的治疗方法来产生多目标疗法。这种额外的口服处理与上述漱录方法一起使用,以确保每个疾病的每个人都有最佳结果,但特别适用于可能已经强调的免疫系统的个体。这种口腔制剂是姜黄素提取物,吹笛子,抗坏血酸,锌,海胆稀土,三年群,艾滋病,Syzygium芳香族,辣味蛋白酶和Zingiber Officinale以及口服姜黄素的制剂。

著录项

  • 公开/公告号US2021308071A1

    专利类型

  • 公开/公告日2021-10-07

    原文格式PDF

  • 申请/专利权人 ANANTHA LAKSHMI THALLAPUREDDY;

    申请/专利号US202117221838

  • 发明设计人 ANANTHA LAKSHMI THALLAPUREDDY;

    申请日2021-04-04

  • 分类号A61K31/045;A61K33/14;A61K9;A61K36/9066;A61K31/12;A61K36/67;A61K33/30;A61K31/375;A61K36/28;A61K36/185;A61K36/8962;A61K36/61;A61K36/53;A61K36/9068;

  • 国家 US

  • 入库时间 2022-08-24 21:30:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号